pembrolizumab
merck
[]
check out our poster: crc patients treated with first line pembrolizumab with metastases that included liver had significantly poorer pfs compared to those with non-liver metastases #crc #gi23 #ascogi 
Research fellow at Mayo Clinic | MD-MPH-MHPE from TUMS '21 | #InternationalBiologyOlympiad '13 | Views are my own | T/RT not endorsement